NEW YORK (360Dx) – Almac Diagnostics has announced that the European Organization for the Research and Treatment of Cancer (EORTC) has tapped the company to establish molecular profiles of cancer patient samples.
The EORTC, with help from Almac Diagnostics laboratory services, seeks to streamline patient inclusion in clinical trials of molecularly targeted treatments, and to standardize next-generation sequencing and gene expression analysis.
Get the full story This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?